These results suggest that BMI1 may induce Sp1 expression in NSCLC cells by inhibiting miR-145-5p, which ultimately increases proliferation and the EMT program in NSCLC and promotes cellular resistance to pemetrexed. The gene discussed is SP1; the disease is non-small cell lung carcinoma.